Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs

To evaluate the onset timing of musculoskeletal adverse events (MAEs) that develop during statin monotherapy and to determine whether concomitant drugs used concurrently with statin therapy shifts the onset timing of MAEs. Cases in which statins (atorvastatin, rosuvastatin, simvastatin, lovastatin,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Res Perspect
Autores principales: Akimoto, Hayato, Negishi, Akio, Oshima, Shinji, Okita, Mitsuyoshi, Numajiri, Sachihiko, Inoue, Naoko, Ohshima, Shigeru, Kobayashi, Daisuke
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220123/
https://ncbi.nlm.nih.gov/pubmed/30443347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.439
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares